A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 3, 1998, Pages 275-280

  Brocklehurst, P ^a   Kinghorn, G ^b   Carney, O ^a   Helsen, K ^b   Ross, E ^a   Ellis, E ^b   Shen, R ^b   Cowan, F ^a   Mindel, A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PLACEBO;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DOUBLE BLIND PROCEDURE; DRUG SCREENING; FEMALE; GENITAL HERPES; HUMAN; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; THIRD TRIMESTER PREGNANCY;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CESAREAN SECTION; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HUMANS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RECURRENCE;

EID: 0031940576     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10086.x     Document Type: Article

References (16)

1. Nahmias AJ, Keyserling HH, Kemck G. Herpes simplex. In: Remington JS, Klein JO editors. Infectious Diseases of the Fetus and Newborn lnfanf. Philadelphia : WB Saunders, 1983: 156–190.
2. Whitley RJ, Arvin A, Prober C et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991; 324: 444–449.
3. Whitely RJ, Nahmias AJ, Vinistine AM et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66: 489–494.
4. Lissauer T, Jeffries D. Preventing neonatal herpes infection. Br J Obsrer Gynaecol 1989; 96: 1015–1018.
5. Randolph AG, Washington E, Prober CG. Caesarean delivery for women presenting with genital herpes lesions. JAMA 1993; 270: 77–82.
6. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1991; 316: 240–243.
7. Mindel A, Brocklehurst P. The treatment of herpes simplex virus infections. In: Jefiies DJ, De Clerq E, editors Antiviral Chemotherapy. Chichester : John Wiley & Sons, 1995: 197–237.
8. Kaplowitz LG, Baker D, Gelb L et al. Prolonged continuous versus intermittent oral acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA 1991; 265: 747–751.
9. Richards DM, Carmine AA, Brogden RN et al. Acyclovir: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1983; 26: 378–438.
10. Andrews EB, Yankaskas BC, Cordero JF, Schoeffler K, Hatnpp S. Acyclovir in pregnancy registry: six years experience. N Engl J Med 1992; 19:7–13.
11. Stray-Pedersen B. Acyclovir in late pregnancy to prevent neonatal herpes simplex [letter]. Lancet 1990; 336: 756.
12. Mindel A, Faherty A, Carney O et al. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988; 1: 926–928.
13. Frenkel LM, Brown ZA, Bryson YJ, Corey L etal. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991; 164: 569–576.
14. Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ. Growth inhibition by acycloguanosine of herpes-viruses isolated from human infections. J Antimicrob Chemother 1979; 15: 642–645.
15. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD. Acyclovir to prevent caesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 81: 69–73.
16. Penn ZJ, Steer PJ, Grant A. A multicentre randomised controlled trial comparing elective and selective caesarean section for the delivery of the preterm breech infant. Br JOhstet Gynaecol 1996; 103: 684–689.